Kira Pharmaceuticals is a clinical-stage biotechnology company pioneering a world free from complement disease
Kira Pharmaceuticals is a clinical-stage biotechnology company pioneering a world free from complement disease. Enabled by its LOGIC platform, the company has developed a robust pipeline of nine novel complement assets focused on validated targets across the complement cascade.